Evidence map›Paper›PMID 30634617›Full record

ArticleMarine drugs2019

Inhibition of Adipogenesis by Diphlorethohydroxycarmalol (DPHC) through AMPK Activation in Adipocytes.

Min-Cheol Kang, Yuling Ding, Hyun-Soo Kim, You-Jin Jeon, Seung-Hong Lee

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Molecules (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Diphlorethohydroxycarmalol Isolated fromInternational journal of molecular sciences · 2021
    Article
  10. Article
  11. Anti-Obesity Effects ofNutrients · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Polyphenol-richPeerJ · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Min-Cheol KangDepartment of Marine Life Sciences, Jeju National University, Jeju 63243, Korea. networksun@naver.com.
Yuling DingDepartment of Pharmaceutical Engineering, Soonchunhyang University, Asan 31538, Korea. dingyuling@naver.com.
Hyun-Soo KimDepartment of Marine Life Sciences, Jeju National University, Jeju 63243, Korea. gustn783@naver.com.
You-Jin JeonDepartment of Marine Life Sciences, Jeju National University, Jeju 63243, Korea. youjinj@jejunu.ac.kr.ORCID 0000-0003-3299-7266
Seung-Hong LeeDepartment of Pharmaceutical Engineering, Soonchunhyang University, Asan 31538, Korea. seunghong0815@gmail.com.
Jeju National University · KRSoonchunhyang University · KRKorea Food Research Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the antiobesity effect and the mechanism of action of diphlorethohydroxycarmalol (DPHC) isolated from

Indexed as

3T3-L1 CellsAdenylate KinaseAdipocytesAdipogenesisAnimalsCell SurvivalGene Expression Regulation, EnzymologicHeterocyclic Compounds, 3-RingMiceMolecular StructureSeaweedAdenylate KinasediphlorethohydroxycarmalolHeterocyclic Compounds, 3-Ringadipocytesadipogenesisantiobesitydiphlorethohydroxycarmalol (DPHC)

Identifiers

PMID30634617
PMCPMC6356311
OpenAlexW2909539549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.